Disseminated Intravascular Coagulation clinical trials
The registry lists 43 studies for Disseminated Intravascular Coagulation across more than 10 countries. 10 are recruiting or about to start. 15 of them are mainly about Disseminated Intravascular Coagulation (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.
Get an email when these change. Save the Disseminated Intravascular Coagulation studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
University Hospital, Strasbourg, France (5) · Bayer (4) · Kyowa Kirin Co., Ltd. (3) · Jubilee Mission Medical College and Research Institute (2) · Assiut University (2) · Shanghai Jiao Tong University School of Medicine (1) · China Medical University, China (1) · Marcella Muller (1)
What is being tested here
Drugs under test in Disseminated Intravascular Coagulation studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 4
- Dec 2026A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy · Bayer
- Apr 2027An Observational Study in the United States to Learn How Venous Thromboembolism, Disseminated Intravascular Coagulation, and Sepsis Are Related · Bayer
- Jul 2027EVALUATION OF NEUTROPHIL FLUORESCENCE IN PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION ASSOCIATED WITH SEPTIC SHOCK · University Hospital, Strasbourg, France
- Nov 2027Fluorescent Leukocytes as a Marker of Early Sepsis/Severity · University Hospital, Strasbourg, France
Who these studies take
Of the 4 Disseminated Intravascular Coagulation studies recruiting now, 2 (50%) set no upper age limit and 0 (0%) stop at 75 or younger. 1 (25%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (25%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 1 (25%) | 1 (25%) |
| 18 | 4 (100%) | 4 (100%) |
| 30 | 4 (100%) | 4 (100%) |
| 40 | 4 (100%) | 4 (100%) |
| 50 | 4 (100%) | 4 (100%) |
| 65 | 4 (100%) | 4 (100%) |
| 75 | 4 (100%) | 4 (100%) |
| 85 | 4 (100%) | 4 (100%) |
Across all 43 studies, recruiting or not: 21% stop at 75 or younger and 19% at 65; 14% take children; 5% are for women only and 0% for men only; 14% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Disseminated Intravascular Coagulation studies take
Of 13 observational studies under Disseminated Intravascular Coagulation, half reached primary completion within 16 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Observational | 16 mo13–21 · 13 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 14, 2026.
Newly registered2
- Early Detection and Kinetics of Sepsis-Induced Coagulopathy in Severe Burn PatientsNov 3, 2026NCT07914205
- Safflower (Carthamus Tinctorius L.) Granules for Sepsis-associated CoagulopathyOct 27, 2026NCT07897006
Studies
Recruiting first, then most recently updated. Showing 43 of 43. search them.
- A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced CoagulopathyRecruitingNCT06854640Phase 15 countries
- Early Detection and Kinetics of Sepsis-Induced Coagulopathy in Severe Burn PatientsRecruitingNCT079142051 country
- Safflower (Carthamus Tinctorius L.) Granules for Sepsis-associated CoagulopathyNot yet recruitingNCT07897006Not applicable1 country
- EARLY DIAGNOSIS OF SEPTIC DICNot yet recruitingNCT076304151 country
- Fluorescent Leukocytes as a Marker of Early Sepsis/SeverityNot yet recruitingNCT075859421 country
- Role of Fibrinolytic Activity in Neoplastic Pathologies Complicated by CoagulopathyNot yet recruitingNCT072346301 country
- EVALUATION OF NEUTROPHIL FLUORESCENCE IN PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION ASSOCIATED WITH SEPTIC SHOCKNot yet recruitingNCT070394871 country
- Longitudinal Cohort of Thrombosis and Hemostasis DiseasesRecruitingNCT067276691 country
- Predictive Value of Scoring System in Neonates with Disseminated Intravascular CoagulationNot yet recruitingNCT06626880
- The Proactive Diagnostic Value of Hemostatic Biomarkers in Disseminated Intravascular CoagulationRecruitingNCT059950931 country
- An Observational Study in the United States to Learn How Venous Thromboembolism, Disseminated Intravascular Coagulation, and Sepsis Are RelatedActive, not recruitingNCT067656811 country
- Effect of Prophylactic Fibrinogen Concentrate In Scoliosis SurgeryCompletedNCT05391412Phase 41 country
- Disseminated Intravascular Coagulation (DIC) Score and Organ Dysfunction in Septic Shock PatientsCompletedNCT063631491 country
- A Study to Assess the Safety and Effects of Different Doses of an Investigational Drug, BAY 3389934, in Healthy Japanese Volunteers.CompletedNCT07176728Phase 11 country
- Study Assessing Efficacy of Plasmatherapy in Septic Shock-induced Coagulopathy: Feasibility StudyCompletedNCT04580563Not applicable1 country
- An Observational Study to Learn About the Occurrence of Disseminated Intravascular Coagulation Among Adults With Sepsis in JapanCompletedNCT063731591 country
- Analysis of the Coagulopathy Developed by COVID-19 Infected PatientsCompletedNCT043569501 country
- PLatelets Acetyl-CoA Carboxylase Phosphorylation State in SEPtic ShockCompletedNCT04107402Not applicable1 country
- Recombinant Human Antithrombin (ATryn®) in the Treatment of Patients With DIC Associated With Severe SepsisTerminatedNCT00506519Phase 2
- Thrombelastography for Coagulopathy in Chinese SnakebitesCompletedNCT068605031 country
- Rotational Thromboelastometry Versus DIC Score in SepsisCompletedNCT046108531 country
- Infusional Fluorouracil and Weekly Docetaxel for Gastric Cancer With Bone Marrow Involvement and DICCompletedNCT04547153Phase 21 country
- Hemostatic Variables In Snakebite StudyCompletedNCT045202821 country
- Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular CoagulationStatus unknownNCT02654561Phase 31 country
- Waveform Analysis In Snakebite Victims With HematotoxicityCompletedNCT038591541 country
- Blood Management During ECMO for Cardiac SupportCompletedNCT037140481 country
- Standardized Olive Leaf Capsules; as a Co-therapy in the Treatment of COVID-19 PatientsCompletedNCT04873349Not applicable1 country
- Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy AdultsCompletedNCT04723602Phase 11 country
- Coagulation Changes Associated With COVID-19 InfectionCompletedNCT044606641 country
- The LEAD COVID-19 Trial: Low-risk, Early Aspirin and Vitamin D to Reduce COVID-19 HospitalizationsWithdrawnNCT04363840Phase 2
- Patient Blood Management for Massive Obstetric HemorrhageCompletedNCT03784794Not applicable1 country
- Thrombomodulin-modified Thrombin Generation Assay (TGA-TM) in Patients With Critical InfectionsCompletedNCT043561441 country
- Effect of Vitamin K in Critically Ill PatientsCompletedNCT037820251 country
- Thromboelastometry Guided DIC Prevention After Cesarean Section in Pregnant Women With Placenta PreviaStatus unknownNCT03266432Not applicable1 country
- Platelet Reactivity in Septic ShockCompletedNCT037163101 country
- International Prospective Registry of Disseminated Intravascular CoagulationStatus unknownNCT035770151 country
- A Clinical Study of KW-3357 in Patients With DICCompletedNCT01384396Phase 31 country
- An Open-label Study of KW-3357CompletedNCT01384903Phase 31 country
- A Phase 3 Clinical Study of KW-3357 in Patients With DICTerminatedNCT01384409Phase 31 country
- Clinical Pharmacokinetics Study of ART-123 in Disseminated Intravascular Coagulation (DIC) Subjects With Renal ImpairmentCompletedNCT01704001Phase 41 country
- Thrombin Generation and Thromboelastography in Non-overt DICTerminatedNCT002999491 country
- 4G/5G Polymorphism of Plasminogen Activator Inhibitor-1 Gene and Disseminated Intravascular Coagulation in Severe Sepsis and Septic ShockStatus unknownNCT01211899
- Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular CoagulationCompletedNCT00487656Phase 24 countries